STOCK TITAN

10x Genomics to Report Third Quarter Financial Results on November 3, 2021

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

10x Genomics (Nasdaq: TXG) will report its third quarter 2021 financial results after market close on November 3, 2021. Management will host a conference call at 1:30 p.m. PT to discuss the results and future business outlook. The call will be accessible via a live webcast on the company’s website, which will also archive the event for 45 days.

10x Genomics focuses on life science technology, providing integrated solutions for biological analysis, adopted by leading global research institutions and cited in over 2,800 research papers.

Positive
  • None.
Negative
  • None.

PLEASANTON, Calif., Oct. 7, 2021 /PRNewswire/ -- 10x Genomics (Nasdaq: TXG) today announced it will report financial results for the third quarter 2021 after market close on Wednesday, November 3rd, 2021. The company's management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook.

Live audio of the webcast will be available on the "Investors" section of the company website at: www.10xgenomics.com. The webcast will be archived and available for replay for at least 45 days after the event.

About 10x Genomics
10x Genomics is a life science technology company building products to interrogate, understand and master biology to advance human health. The company's integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. 10x Genomics products have been adopted by researchers around the world including in all of the top 100 global research institutions as ranked by Nature in 2020 based on publications and all of the top 20 global pharmaceutical companies by 2020 research and development spend and have been cited in over 2,800 research papers on discoveries ranging from oncology to immunology and neuroscience. The company's patent portfolio comprises more than 1,150 issued patents and patent applications.

Disclosure Information
10x Genomics uses filings with the Securities and Exchange Commission, its website (www.10xgenomics.com), press releases, public conference calls, public webcasts and its social media accounts as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.

 

Cision View original content:https://www.prnewswire.com/news-releases/10x-genomics-to-report-third-quarter-financial-results-on-november-3-2021-301395706.html

SOURCE 10x Genomics, Inc

FAQ

When will 10x Genomics report its third quarter 2021 financial results?

10x Genomics will report its third quarter financial results on November 3, 2021, after market close.

What will 10x Genomics discuss during the November 3 conference call?

Management will discuss the third quarter financial results, business developments, and future outlook.

How can I access the webcast for 10x Genomics' financial results?

The webcast will be available on the 'Investors' section of the company's website, and it will be archived for at least 45 days.

10x Genomics, Inc.

NASDAQ:TXG

TXG Rankings

TXG Latest News

TXG Stock Data

1.68B
103.97M
2.17%
94.44%
6.28%
Health Information Services
Laboratory Analytical Instruments
Link
United States of America
PLEASANTON